pantoprazole and cgp 74588

pantoprazole has been researched along with cgp 74588 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Beijnen, JH; Buckle, T; Oostendorp, RL; Schellens, JH; van Tellingen, O	1

Other Studies

1 other study(ies) available for pantoprazole and cgp 74588

Article	Year
The effect of P-gp (Mdr1a/1b), BCRP (Bcrp1) and P-gp/BCRP inhibitors on the in vivo absorption, distribution, metabolism and excretion of imatinib. Investigational new drugs, 2009, Volume: 27, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Absorption; Acridines; Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Benzamides; Bile; Brain; Drug Combinations; Drug Resistance, Neoplasm; Feces; Female; Imatinib Mesylate; Kidney; Liver; Metabolic Clearance Rate; Mice; Mice, Knockout; Pantoprazole; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Tetrahydroisoquinolines	2009

Article

Year

The effect of P-gp (Mdr1a/1b), BCRP (Bcrp1) and P-gp/BCRP inhibitors on the in vivo absorption, distribution, metabolism and excretion of imatinib.

Investigational new drugs, 2009, Volume: 27, Issue:1

Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Absorption; Acridines; Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Benzamides; Bile; Brain; Drug Combinations; Drug Resistance, Neoplasm; Feces; Female; Imatinib Mesylate; Kidney; Liver; Metabolic Clearance Rate; Mice; Mice, Knockout; Pantoprazole; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Tetrahydroisoquinolines

2009